Double Bond Pharmaceutical Competitors and Similar CompaniesClear all

Double Bond Pharmaceutical's competitors and similar companies include Pharmstandard.
Double Bond Pharmaceutical
Double Bond Pharmaceutical
Double Bond Pharmaceutical is a company that develops approaches for treatment of cancers.
Pharmstandard
Pharmstandard
Pharmstandard (also known as АО Фармстандарт) is a company that develops and manufactures pharmaceutical products.
Founding Date
Founding Date
2014
Founding Date
2003
Type
Type
Public
Type
Subsidiary
Tags
Locations
Locations
Uppsala, SE HQ
Uppsala, SE
Locations
Dolgoprudny, RU HQ
Kursk, RU
Moscow, RU
Petrovo Dalnee, RU
Tomsk, RU
Ufa, RU
Vol'ginskii, RU
Employees
Employees
1318% increase
Employees
1,77814% increase

Financial

Revenue (est.)
Revenue (est.)
kr84k (FY, 2025)
Revenue (est.)
₽152.1b (FY, 2024)
Cost of goods
Cost of goods
kr125k (FY, 2025)
Cost of goods
₽117b (FY, 2024)
Gross profit
Gross profit
(kr25k) (FY, 2025)
Gross profit
₽35.2b (FY, 2024)
Net income
Net income
(kr333k) (FY, 2025)
Net income
₽22.7b (FY, 2024)
For sources of this data, please see the company profile

View Company Profiles

Pharmstandard
HQ
Dolgoprudny, RU

Pharmstandard (also known as АО Фармстандарт) is a company that develops and manufactures pharmaceutical products.

View company